Literature DB >> 7489472

Paediatric ventilatory effects of morphine and buprenorphine revisited.

K T Olkkola1, M A Leijala, E L Maunuksela.   

Abstract

The study describes long term ventilatory effects of 50 or 100 micrograms.kg-1 of morphine or 1.5 or 3.0 micrograms.kg-1 of buprenorphine when given in repeated intravenous (i.v.) doses, in a double blind fashion, to achieve equal levels of analgesia after thoracotomy. The patients were 56 children, six months to six years of age. Ventilatory rate (VR) was measured over the 24 h study period, and arterial carbon dioxide tension (PaCO2) was measured on arrival in the Paediatric Intensive Care Unit (PICU) and at 1, 6, 12 and 18 h. In the buprenorphine groups VRs progressively decreased during the first 2 h and remained significantly lower (P < 0.05) than in the morphine groups for 7 h. For the rest of the study period there were no differences. The PaCO2 values did not differ significantly at any point. For safety, prolonged observation of children is needed after intravenous administration of buprenorphine to ensure the ventilatory rate has stabilized.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489472     DOI: 10.1111/j.1460-9592.1995.tb00311.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  5 in total

Review 1.  [Buprenorphine in children. A clinical and pharmacological review].

Authors:  E Michel; B Zernikow
Journal:  Schmerz       Date:  2006-02       Impact factor: 1.107

2.  [Long-term pediatric opioid based pain control. Case reports].

Authors:  B Zernikow; C Schiessl; C Wamsler; N Griessinger; R Sittl
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

Review 3.  Management of opioid analgesic overdose.

Authors:  Edward W Boyer
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

Review 4.  Buprenorphine versus Morphine in Paediatric Acute Pain: A Systematic Review and Meta-Analysis.

Authors:  Nathan Murray; Utsav Malla; Ruan Vlok; Alice Scott; Olivia Chua; Thomas Melhuish; Leigh White
Journal:  Crit Care Res Pract       Date:  2018-08-07

5.  Transdermal buprenorphine in the management of persistent pain - safety aspects.

Authors:  Rudolf Likar
Journal:  Ther Clin Risk Manag       Date:  2006-03       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.